Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty

NCT03973320 | Completed Results

• 1 other identifier: 2018-2235
• Study Type: observational
• Target: 11,292
• Locations: 1 country
• Sites: 1

Brief Summary

This is a retrospective chart review to determine if neuraxial anesthesia is associated with worse outcomes after Primary Total Hip Arthroplasty.

Conditions

Total Hip Arthroplasty; Primary Total Hip Arthroplasty; Hypotension; Database

Outcome Measures

Primary Outcomes (1)

• Number of Participants Who Experience Myocardial Infarction, Cerebrovascular Accident, or Mortality

  The association between levels and length of intraoperative controlled hypotension and incidence rates of individual and composite outcome of any of the following events: (i) myocardial infarction (MI), (ii) cerebrovascular accident (CVA), (iii) death. If any of these events are positive, then the composite outcome will be positive. The units of measurement will be the same.

  Day of Surgery (Day 0) through discharge (days til discharge is an average of 2 days), follow-ups up to 30 days post-surgery

Study Arms (1)

Primary Total Hip Arthroplasty

This is a chart review to determine if hypotensive neuraxial anesthesia is associated with worse outcomes in Primary Total Hip Arthroplasty

Other: Chart Review

Interventions

Chart Review OTHER

This is a chart review to determine if hypotensive neuraxial anesthesia is associated with worse outcomes in Primary Total Hip Arthroplasty patients.

Primary Total Hip Arthroplasty

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients undergoing Primary Total Hip Arthroplasty

You may qualify if:

• All primary total hip arthroplasty patient data with sufficiently complete intraoperative vital signs

You may not qualify if:

• Revision primary total hip arthroplasty
• Incomplete intraoperative vital signs
• Anterior total hip arthroplasty

Sponsors & Collaborators

• Hospital for Special Surgery, New York: lead

Study Sites (1)

Hospital for Special Surgery

New York, New York, 10021, United States

Location

MeSH Terms

Conditions

Hypotension

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases

Results Point of Contact

• Title: Dr. Jiabin Liu
• Organization: Hospital for Special Surgery, Anesthesiology

liuji@hss.edu

2126061036

Study Officials

• Jiabin Liu, MD, PhD

  Hospital for Special Surgey

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 28, 2019
• First Posted: June 4, 2019
• Study Start: December 27, 2018
• Primary Completion: November 18, 2019
• Study Completion: November 18, 2019
• Last Updated: December 27, 2024
• Results First Posted: April 5, 2024

Record last verified: 2024-03

Locations

US (1)